Halozyme Therapeutics Inc (HALO)
44.71
-0.68
(-1.50%)
USD |
NASDAQ |
May 17, 16:00
44.73
+0.02
(+0.04%)
Pre-Market: 20:00
Halozyme Therapeutics Price: 44.71 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 45.36 | 45.76 | 44.35 | 44.71 | 1.102M |
May 16, 2024 | 45.86 | 46.16 | 45.22 | 45.39 | 1.037M |
May 15, 2024 | 44.26 | 46.05 | 44.01 | 45.82 | 1.262M |
May 14, 2024 | 44.03 | 45.18 | 43.55 | 43.82 | 1.102M |
May 13, 2024 | 43.49 | 44.01 | 43.36 | 43.61 | 908693.0 |
May 10, 2024 | 44.08 | 44.21 | 43.12 | 43.15 | 1.032M |
May 09, 2024 | 42.20 | 43.92 | 41.28 | 43.84 | 1.441M |
May 08, 2024 | 41.95 | 44.78 | 41.43 | 42.01 | 2.121M |
May 07, 2024 | 41.10 | 41.66 | 40.87 | 41.21 | 1.282M |
May 06, 2024 | 40.36 | 40.97 | 40.18 | 40.86 | 981079.0 |
May 03, 2024 | 40.67 | 40.74 | 39.79 | 39.91 | 902802.0 |
May 02, 2024 | 39.56 | 40.74 | 38.88 | 39.82 | 832175.0 |
May 01, 2024 | 38.40 | 40.00 | 38.30 | 39.30 | 1.032M |
Apr 30, 2024 | 38.54 | 39.03 | 37.96 | 38.10 | 922527.0 |
Apr 29, 2024 | 38.76 | 39.39 | 38.56 | 38.77 | 728580.0 |
Apr 26, 2024 | 38.46 | 39.02 | 38.46 | 38.57 | 547134.0 |
Apr 25, 2024 | 38.71 | 38.75 | 38.23 | 38.46 | 693350.0 |
Apr 24, 2024 | 38.98 | 39.70 | 38.82 | 39.12 | 620516.0 |
Apr 23, 2024 | 38.75 | 39.42 | 38.70 | 38.97 | 557948.0 |
Apr 22, 2024 | 38.82 | 39.04 | 38.28 | 38.71 | 525232.0 |
Apr 19, 2024 | 37.73 | 38.69 | 37.73 | 38.64 | 1.259M |
Apr 18, 2024 | 37.95 | 38.41 | 37.73 | 37.81 | 792530.0 |
Apr 17, 2024 | 38.69 | 38.78 | 37.98 | 38.02 | 733857.0 |
Apr 16, 2024 | 38.35 | 38.81 | 38.08 | 38.38 | 642294.0 |
Apr 15, 2024 | 38.89 | 39.27 | 38.48 | 38.72 | 843658.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.90
Minimum
Mar 18 2020
59.44
Maximum
Dec 02 2022
35.39
Average
38.46
Median
Apr 25 2024
Price Benchmarks
Novavax Inc | 13.01 |
Globus Medical Inc | 64.45 |
Denali Therapeutics Inc | 20.52 |
AIM ImmunoTech Inc | 0.403 |
Protalix BioTherapeutics Inc | 1.14 |
Price Related Metrics
PE Ratio | 18.48 |
PS Ratio | 6.834 |
PEG Ratio | 0.218 |
Price to Book Value | 32.00 |
Price to Free Cash Flow | 13.92 |
Earnings Yield | 5.41% |
Market Cap | 5.690B |
PEGY Ratio | 0.218 |
Operating PE Ratio | 15.55 |
Normalized PE Ratio | 20.07 |